Medication-info.com Search Menu

Demerol: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Controlled substance Schedule II Boxed warning Current since October 21, 2026
Strength:
50 mg/mL, 25 mg/mL, 75 mg/mL, 100 mg/mL
Drug class:
Active ingredient:
Similar drugs:

Source: FDA drug labeling via NLM DailyMed · About this document

Patient information: uses, side effects, how to take - Demerol

INSTRUCTIONS FOR USE

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to ‎administration, whenever solution and container permit. Do not use if color is darker than pale yellow, if it ‎is discolored in any other way, or if it contains a precipitate.

Instructions for use - Carpuject™ Single-dose Cartridge

Carpuject™ Single-dose cartridges with Luer Lock are packaged in a Slim-Pak™ tamper detection package. Note that a needle is not included.

Before use, read all instructions for using the Carpuject™ Syringe, which are contained in the product insert for‎ the reusable Carpuject™ Holder before use.

Carpuject™ Single-dose cartridges are to be used ONLY with Carpuject™ Holders.

NOTE: To prevent needlestick injuries, do not recap, purposely bend, or break by hand used ‎needles. Do not recap, purposely bend, or break by hand blunt Cannulas.

Instructions for use - NexJect™ Single-dose Prefilled Syringe

NOTE: To prevent needlestick injuries, do not recap, purposely bend, or break by hand used ‎needles. Do not recap, purposely bend, or break by ‎hand blunt Cannulas.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

LAB-1387-2.0

Revised: 12/2023

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 021171 · View the label on DailyMed

Revision date stated in the text: December 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Demerol

Rx or OTC
Prescription (Rx), Controlled substance?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • This drug is a controlled substance under the federal Controlled Substances Act.
  • Rx
Controlled substance Schedule IISchedule II: high potential for abuse; abuse may lead to severe psychological or physical dependence.
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Opioid Agonist
Active ingredient Meperidine hydrochloride
Dosage form Injection, solution
Route Intramuscular, Intravenous, Subcutaneous
Marketing status listed in the FDA NDC Directory
Company (applicant) HOSPIRA
FDA approval NDA 021171New Drug Application (NDA) Approved November 10, 1942
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Therapeutic equivalence (TE) code APCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 1 labelers list this drug on DailyMed
Drug shortage
  • Current since October 21, 2026
Packages (NDC)
Package
50 mg/mL – 30 ml in 1 vial, multi-dose / 1 in 1 carton NDC 0409-1181-30
50 mg/mL – 1 ml in 1 cartridge / 10 in 1 carton NDC 0409-1178-03
50 mg/mL – 1 ml in 1 syringe / 10 in 1 cello pack NDC 0409-1418-11
25 mg/mL – 1 ml in 1 cartridge / 10 in 1 carton NDC 0409-1176-03
25 mg/mL – 1 ml in 1 syringe / 10 in 1 cello pack NDC 0409-1362-11
75 mg/mL – 1 ml in 1 cartridge / 10 in 1 carton NDC 0409-1179-03
100 mg/mL – 1 ml in 1 cartridge / 10 in 1 carton NDC 0409-1180-59

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.